Protection against chemotherapy induced mucositis by TGF‐β₂ in childhood cancer patients: Results from a randomized cross‐over study

Abstract

TGF-beta(2) administration via feeding is well tolerated and safe. Although this study might have had limitations to show potential benefit of TGF-beta(2), it does not provide evidence that TGF-beta(2) decreases the incidence or degree of mucositis induced by combination chemotherapy in childhood-cancer patients.